Computational modeling of signal transduction pathways in breast cancerous cell and target therapy

ISSN: 22773878
0Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.

Abstract

In this paper we identify the mutated signal transduction pathways in a breast cancerous cell. A simulated model is developed for these pathways. To reduce cancer some drugs are suggested that are helpful in correcting the pathways. Some of the pathways like PKB (Protein Kinase B), MAPK (Mitogen Activated Protein Kinase), MTOR (Mammalian Target Of Rapamycin), Fas Ligand (Type-II Tran membrane Protein), Notch (Single Pass Transmembrane Receptor), SHH (Sonic Hedgehog), Tnf (Tumor Necrosis Factor), Wnt (Wingless/Integrated) Pathways are simulated. Converting these biological pathways into a computable model helps in analyzing it rapidly. For Computational modeling of signal transduction pathways, SBML (Systems Biology Markup Language) is used. Programming is done in SBML and executed in Cell Designer. In this paper simulated models of PKB, MAPK, MTOR, FasL, Notch, SHH, Tnf, Wnt pathways are developed and shown in the results. Target Therapy can be implemented to these pathways. Drugs like Wortmannin, Perifosine and Rapamycin are suggested. These drugs help in modifying the pathways in such a way that, their metabolism is converted into the metabolism of a normal breast cell. This helps in reducing breast cancer.

Cite

CITATION STYLE

APA

Golagani, P. P., Beebi, S. K., & Mahalakshmi, T. S. (2019). Computational modeling of signal transduction pathways in breast cancerous cell and target therapy. International Journal of Recent Technology and Engineering, 8(1), 1170–1175.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free